Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients

Anesthesiology

Volumn 85, Issue 6, 1996, Pages 1311-1323

  Despotis, George J ^a   Levine, Vladimir ^a   Filos, Kriton S ^d   Santoro, Samuel A ^a   Joist, J Heinrich ^b   Spitznagel, Edward ^c   Goodnough, Lawrence T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF PATRAS   (Greece)

Author keywords

Coagulation: platelet count; platelet procoagulant function; Monitoring: coagulation; Surgery: cardiac

Indexed keywords

DESMOPRESSIN ACETATE; KAOLIN; PROCOAGULANT; PROTAMINE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD CLOT; BLOOD CLOTTING; BLOOD CLOTTING TIME; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

AGED; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; DEAMINO ARGININE VASOPRESSIN; EVALUATION STUDIES; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATING FACTOR; PLATELET TRANSFUSION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RENAL AGENTS; WHOLE BLOOD COAGULATION TIME;

EID: 0030461052     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199612000-00012     Document Type: Article

References (47)

1. Hardy JF, Perrault J, Tremblay N, Robitaille D, Blain R, Carrier M: The stratification of cardiac surgical procedures according to use of blood products: A retrospective analysis of 1480 cases. Can J Anaesth 1991; 38:511-7
2. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Cox JL, Barnes P, Lappas DG: Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1994; 107:271-9
3. Khuri SF, Wolfe JA, Josa M, Axford TC, Szymanski I, Assousa S, Ragno G, Patel M, Silverman A, Park M: Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992; 104:94-107
4. Despotis GJ, Filos KS, Zoys TN, Hogue CWJ, Spitznagel E, Lappas DG: Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients. Anesth Analg 1996; 82:13-21
5. Woodman RC, Harker LA: Bleeding complications associated with cardiopulmonary bypass [Review]. Blood 1990; 76:1680-97
6. Czer LS: Mediastinal bleeding after cardiac surgery: Etiologies, diagnostic considerations, and blood conservation methods [Review]. J Cardiothorac Anesth 1989; 3:760-75
7. Harker LA: Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314:1446-8
8. George JN, Shattil SJ: The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991; 324:27-39
9. Kalter RD, Saul CM, Wetstein L, Soriano C, Reiss RF: Cardiopulmonary bypass. Associated hemostatic abnormalities. J Thorac Cardiovasc Surg 1979; 77:427-35
10. Shainoff JR, Estafanous FG, Yared JP, DiBello PM, Kottke-Marchant K, Loop FD: Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994; 108:437-45
11. Holloway DS, Summaria L, Sandesara J, Vagher JP, Alexander JC, Caprini JA: Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988; 59:62-7
12. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR: Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. ANESTHESIOLOGY 1991; 75:563-70
13. Sloand EM, Alyono D, Klein HG, Chang P, Yu M, Lightfoot FG, Kessler C: 1-Deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein 1b in patients with disorders of platelet function and after cardiopulmonary bypass. Am J Hematol 1994; 46:199-207
14. Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R: Platelet activation and aggregation during cardiopulmonary bypass. ANESTHESIOLOGY 1991; 75:388-93
15. Beurling-Harbury C, Galvan CA: Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients and in patients with severe valvular heart disease. Blood 1978; 52:13-23
16. Counts RB: Causes of bleeding in open-heart surgery, Transfusion Practice in Cardiac Surgery. Edited by Baldwin ML, Kurtz SR. Arlington, American Association of Blood Banks, 1991, pp 1-10
17. Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG: The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective, randomized evaluation in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1995; 110:46-54
18. Ray MJ, Hawson GA, Just SJ, McLachlan G, O'Brien M: Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 1994; 57:981-6
19. Burns ER, Billett HH, Frater RW, Sisto DA: The preoperative bleeding time as a predictor of postoperative hemorrhage after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1986; 92:310-2
20. Ramsey G, Arvan DA, Stewart S, Blumberg N: Do preoperative laboratory tests predict blood transfusion needs in cardiac operations? J Thorac Cardiovasc Surg 1983; 85:564-9
21. Dorman BH, Spinale FG, Bailey MK, Kratz JM, Roy RC: Identification of patients at risk for excessive blood loss during coronary artery bypass surgery: Thromboelastography versus coagulation screen. Anesth Analg 1993; 76:694-700
22. Gravlee GP, Arora S, Lavender SW, Mills SA, Hudspeth AS, Cordell AR, James RL, Brockschmidt JK, Stuart JJ: Predictive value of blood clotting tests in cardiac surgical patients. Ann Thorac Surg 1994; 58:216-21
23. Tuman KJ, Spiess BD, McCarthy RJ, Ivankovich AD: Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 1989; 69:69-75
24. Mongan PD, Hosking MP: The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. ANESTHESIOLOGY 1992; 77:38-46
25. Wang JS, Lin CY, Hung WT, O'Connor MF, Thisted RA, Lee BK, Karp RB, Yang MW: Thromboelastogram fails to predict postoperative hemorrhage in cardiac patients. Ann Thorac Surg 1992; 53: 435-9
26. Greilich PE, Carr ME Jr, Carr SL, Chang AS: Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage. Anesth Analg 1995; 80:459-65
27. Harker LA, Malpass TW, Branson HE, Hessel EA II, Slichter SJ: Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective alpha-granule release. Blood 1980; 56:824-34
28. Moorehead MT, Westengard JC, Bull BS: Platelet involvement in the activated coagulation time of heparinized blood. Anesth Analg 1984; 63:394-8
29. Moliterno DJ, Califf RM, Aguirre FV, Anderson K, Sigmon KN, Weisman HF, Topol EJ: Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complications trial. Am J Cardiol 1995; 75:559-62
30. Lynch JM, Lotner GZ, Betz SJ, Henson PM: The release of a platelet-activating factor by stimulated rabbit neutrophils. J Immunol 1979; 123:1219-26
31. Snyder F: Biochemistry of platelet-activating factor: A unique class of biologically active phospholipids. Proc Soc Exp Biol Med 1989; 190:125-35
32. Hanahan DJ, Buxton D, Halvorsen O, Olson MS: Platelet-activating factor: A unique lipid chemical mediator. Adv Prostaglandin Thromboxane Leukot Res 1985; 15:707-9
33. Mannucci PM, Canciani MT, Rota L, Donovan BS: Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Br J Haematol 1981; 47:283-93
34. Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS: Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983; 308:8-12
35. Burroughs AK, Matthews K, Qadiri M, Thomas N, Kernoff P, Tuddenham E, McIntyre N: Desmopressin and bleeding time in patients with cirrhosis. BMJ 1985; 291:1377-81
36. Salzman EW, Weinstein MJ, Weintraub RM, Ware JA, Thurer RL, Robertson L, Donovan A, Gaffney T, Bertele V, Troll J: Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med 1986; 314:1402-6
37. Dilthey G, Dietrich W, Spannagl M, Richter JA: Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. J Cardiothorac Vasc Anesth 1993; 7:425-30
38. Hackmann T, Gascoyne RD, Naiman SC, Growe GH, Burchill LD, Jamieson WR, Sheps SB, Schechter MT, Townsend GE: A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. N Engl J Med 1989; 321:1437-43
39. Mannucci PM, Aberg M, Nilsson IM, Robertson B: Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 1975; 30:81-93
40. Beck KH, Bleckmann U, Mohr P, Kretschmer V: DDAVP's shortening of the bleeding time seems due to plasma von Willebrand factor. Semin Thromb Hemost 1995; 21(suppl 2):40-3
41. Lazenby WD, Russo I, Zadeh BJ, Zelano JA, Ko W, Lynch CC, Isom OW, Krieger KH: Treatment with desmopressin acetate in routine coronary artery bypass surgery to improve postoperative hemostasis. Circulation 1990; 82:IV413-9
42. Ghosh S, Rao AK: Lack of effect of 1-desamino-8-D-arginine vasopressin on direct adhesion of platelets to collagen. Thromb Res 1993; 70:417-22
43. Sakariassen KS, Cattaneo M, v.d.Berg A, Ruggeri ZM, Mannucci PM, Sixma JJ: DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 1984; 64:229-36
44. Cattaneo M, Lombardi R, Bettega D, Lecchi A, Mannucci PM: Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine. Arterioscler Thromb Vasc Biol 1993; 13:393-7
45. Horstman LL, Valle-Riestra BJ, Jy W, Wang F, Mao W, Ahn YS: Desmopressin (DDAVP) acts on platelets to generate platelet microparticles and enhanced procoagulant activity. Thromb Res 1995; 79:163-74
46. Lattuada A, Varanukulsak P, Castaman GC, Mannucci PM: The response of plasma von Willebrand factor to desmopressin (DDAVP) is related to the platelet levels of von Willebrand factor. Thromb Res 1992; 67:467-71
47. Kanwar S, Woodman RC, Poon MC, Murohara T, Lefer AM, Davenpeck KL, Kubes P: Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules. Blood 1995; 86:2760-6